BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3885985)

  • 1. Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina.
    Rae AP; Beattie JM; Lawrie TD; Hutton I
    Br J Clin Pharmacol; 1985 Mar; 19(3):343-52. PubMed ID: 3885985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial.
    Nielsen HK; Krusell LR; Husted SE; Pluymers RJ
    Int J Cardiol; 1989 Jun; 23(3):357-64. PubMed ID: 2500401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination propranolol and bepridil therapy in stable angina pectoris.
    Frishman WH; Charlap S; Farnham DJ; Sawin HS; Michelson EL; Crawford MH; DiBianco R; Kostis JB; Zellner SR; Michie DD
    Am J Cardiol; 1985 Mar; 55(7):43C-49C. PubMed ID: 3883741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
    Shapiro W; DiBianco R; Thadani U
    Am J Cardiol; 1985 Mar; 55(7):36C-42C. PubMed ID: 3919556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of bepridil in patients with chronic stable angina pectoris: results of a multicenter, placebo-controlled study of extended bepridil use.
    DiBianco R; Katz RJ; Chesler E; Alpert JS; Spann JF
    Am J Cardiol; 1985 Mar; 55(7):50C-54C. PubMed ID: 3919557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.
    Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C
    Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
    DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
    Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term bepridil monotherapy for angina pectoris.
    Sharma MK; Voyles W; Prasad R; Teague SM; Thadani U
    Am J Cardiol; 1988 Jun; 61(15):1210-3. PubMed ID: 3287882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
    Frishman WH
    Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bepridil for the treatment of angina pectoris: evidence for preservation of left ventricular function.
    Zusman RM; Christensen DM; Kanarek DJ; Kiess MC; Boucher CA
    Am J Cardiol; 1985 Mar; 55(7):30C-35C. PubMed ID: 3919555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1984 Jan; 53(1):29-34. PubMed ID: 6419578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bepridil in stable angina of effort: a double-blind comparison with verapamil].
    Matteoli S; Trappolini M; Galli V; Federici AR; Borgia MC; Greco V
    Cardiologia; 1988 Apr; 33(4):413-8. PubMed ID: 3044589
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled clinical trial of bepridil, propranolol and placebo in the treatment of exercise induced angina pectoris. B.I.S. Research Group.
    Destors JM; Boissel JP; Philippon AM; Schbath J
    Fundam Clin Pharmacol; 1989; 3(6):597-611. PubMed ID: 2515136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of nicardipine and propranolol for chronic stable angina pectoris.
    McGill D; McKenzie W; McCredie M
    Am J Cardiol; 1986 Jan; 57(1):39-43. PubMed ID: 3510524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
    Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all anti anginal agents the same? Comparative evaluation of seven calcium channel blockers with placebo and propranolol in patients with chronic stable angina.
    Subramanian VB
    Indian Heart J; 1988; 40(2):113-25. PubMed ID: 3056849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.